| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |